Abstract: An analog-digital converter may include: an analog-digital converter comprising: a ramp signal selection unit suitable for receiving ramp signals having different offsets, and sequentially selecting one of the ramp signals according to a preset order; a comparison unit suitable for comparing the magnitudes of the selected ramp signal with a pixel signal, and outputting a comparison signal according to the comparison result; and a counting unit suitable for counting the number of clocks of a clock signal until the comparison signal transitions, and outputting a count signal based on the count when the comparison signal transitions.

Abstract: An apparatus and a method for the disclosure relates to an artificial intelligence (AI) system that simulates functions such as recognition and determination of the human brain by using a machine training algorithm such as deep learning and an application of the AI system are provided. A neural network training method includes obtaining target modality signals of a first domain aligned in a time order and auxiliary modality signals of a second domain that are not aligned in the time order, extracting characteristic information of the target modality signals using a first neural network model, estimating the time order of the auxiliary modality signals using a second neural network model, and training the first neural network model based on a result of the estimation and the characteristic information.

Abstract: Systems, methods and apparatus for categorizing electronic content. In one example, the system, method, and apparatus include receiving electronic content items; analyzing textual data and metadata associated with the electronic content items; generating a project workspace based on information associated with one selected from a group consisting of a user of the computing device, the electronic content items, textual data and metadata associated with the electronic content items; categorizing the electronic content items into the project workspace based on intrinsic data and extrinsic data associated with the user; and displaying the project workspace and the electronic content items associated with the project workspace.

Abstract: The pharmacokinetics and key technologies of the present invention are summarized in FIG. 1. Particularly, malignant misfolded proteins such as mutant huntingtin and alpha-synuclein are coagulated and grow into oligomeric coagulum ({circle around (1)}, {circle around (2)}, fibrillar coagulum ({circle around (3)}) and eventually inclusion body ({circle around (4)}). Young neurons produce a large amount of Nt-Arg through N-terminal arginylation ({circle around (5)}) of vesicle chaperones such as BiP secreted into the cytoplasm, and then arginylated BiP (R-BiP) is secreted binds to the misfolded proteins ({circle around (6)}). As a ligand, the Nt-Arg of R-BiP binds to the p62 ZZ domain ({circle around (7)}), and the normally inactivated closed form of p62 is changed to an open form, leading to structural activation ({circle around (8)}). As a result, PB1 and LC3-binding domains are exposed.

Abstract: Provided is a side impact airbag which is deployed between two seats in the width direction of a vehicle to thereby prevent passengers seated on the two seats from colliding with each other. The airbag is configured to, when being fully inflated, form recesses on both sides thereof to accommodate the shoulders and arms of the passengers, such that the fully inflated airbag is configured to be maintained in a certain posture by the pressure applied to the shoulders and arms of the passengers accommodated in the recesses.

Abstract: An analog-digital converter may include: an analog-digital converter comprising: a ramp signal selection unit suitable for receiving ramp signals having different offsets, and sequentially selecting one of the ramp signals according to a preset order; a comparison unit suitable for comparing the magnitudes of the selected ramp signal with a pixel signal, and outputting a comparison signal according to the comparison result; and a counting unit suitable for counting the number of clocks of a clock signal until the comparison signal transitions, and outputting a count signal based on the count when the comparison signal transitions.

Abstract: The present disclosure provides an image sensor. An image sensor may include: a transfer gate formed over a first substrate, and having a through-hole; a column-shaped epitaxial body having a first portion filled in the through-hole and a second portion formed over the transfer gate; a photoelectric conversion element formed in the second portion of the epitaxial body; and a floating diffusion region formed in the first substrate, and contacting the first portion of the epitaxial body.

Abstract: A vehicle airbag includes a main panel to form a main chamber deployed toward an inner part of a vehicle, and a protrusion panel provided outside the main panel to form at least one protrusion chamber that communicates with the main chamber and protrudes toward the inner part of the vehicle based on the main chamber. The protrusion panel is folded to have a wrinkle part when the vehicle airbag is not inflated.

Abstract: The present invention relates to a method for protecting a kidney, which comprises administering an extracellular polysaccharide produced by Ceriporia lacerata; a mycelial culture medium of Ceriporia lacerata containing the extracellular polysaccharide; dried powders of the mycelial culture medium; or an extract of the mycelial culture medium, in an effective amount, to a subject in need of protecting a kidney. The method is effective in protecting a kidney from renal toxicity caused by an anti-cancer agent.

Abstract: An image sensor includes a color filter configured to pass a specific color of light; a micro lens formed under the color filter and configured with a plurality of layers in which an upper layer has a smaller area than a lower layer; and a photo device formed under the micro lens and configured to receive light passing through the micro lens and convert the received light into an electrical signal.

Abstract: The present invention relates to a method for protecting a kidney, which comprises administering an extracellular polysaccharide produced by Ceriporia lacerata; a mycelial culture medium of Ceriporia lacerata containing the extracellular polysaccharide; dried powders of the mycelial culture medium; or an extract of the mycelial culture medium, in an effective amount, to a subject in need of protecting a kidney. The method is effective in protecting a kidney from renal toxicity caused by an anti-cancer agent.

Abstract: A CMOS image sensor includes a hardware-implemented timing signal generation module that generates a timing signal based on a timing pattern generated by a software-implemented timing pattern generation and control module.

Abstract: A lens shading compensation coefficient compression device includes: a first differential block suitable for calculating a lens shading compensation coefficient between color channels and removing redundancy between the color channels; a second differential block suitable for calculating a lens shading compensation coefficient within color channels and removing redundancy within the color channels; and an entropy coding block suitable for performing entropy coding on remaining lens shading compensation coefficients and compressing the lens shading compensation coefficients.

Abstract: The present disclosure provides an image sensor. An image sensor may include: a transfer gate formed over a first substrate, and having a through-hole; a column-shaped epitaxial body having a first portion filled in the through-hole and a second portion formed over the transfer gate; a photoelectric conversion element formed in the second portion of the epitaxial body; and a floating diffusion region formed in the first substrate, and contacting the first portion of the epitaxial body.

Abstract: The present invention provides a method for separating and preparing a therapeutic agent for chronic myelogenous leukimeia capable of effectively inhibiting growth of T315I, which is known as a mutation of a BCR-ABL fusion gene that causes chronic myelogenous leukemia, comprising the steps of: 1) preliminary extracting by adding ethyl acetate to finely chopped bark of Liriodendron tulipifera L., adding butanol to an extracted fluid for layer-separating an ethyl acetate layer and a butanol layer, removing the butanol layer, and decompression-condensing the remainder to obtain a crude extract; and 2) adding a C1-C3 lower alcohol aqueous solution and n-hexane to the obtained crude extract, removing lipids and water insoluble material dissolved in the n-hexane layer, and obtaining and separating a lower alcohol aqueous solution layer to separate and refine highly pure epi-tulipinolide and costunolide.

Abstract: The present invention relates to a pharmaceutical composition containing, as an active ingredient, a Liriodendron tulipifera L. bark extract for treating chronic myelogneous leukemia. More specifically, the present invention relates to the pharmaceutical composition, containing, as the active ingredient, the Liriodendron tulipifera L. bark extract useful in selectively inhibiting mutant enzyme T315I from a mutation of a BCR-ABL fusion gene that causes chronic myelogenous leukemia, and to a use of epi-Tulipinolide which is an active ingredient of the composition.

Abstract: A lens shading compensation coefficient compression device includes: a first differential block suitable for calculating a lens shading compensation coefficient between color channels and removing redundancy between the color channels; a second differential block suitable for calculating a lens shading compensation coefficient within color channels and removing redundancy within the color channels; and an entropy coding block suitable for performing entropy coding on remaining lens shading compensation coefficients and compressing the lens shading compensation coefficients.

Abstract: The present invention relates to a biodegradable suture-type cell delivery system, a preparation method thereof and a biodegradable suture comprising the same. The biodegradable suture-type cell delivery system has improved cell compatibility as a result of depositing a hydrophilic functional group-containing compound on the surface of a biodegradable suture yarn made of a biodegradable polymer, a portion of which has partially a bulky structure beneficial for the proliferation of cells or living tissue, so as to hydrophilically modify the surface, and then bonding a cell compatible material to the surface, and also functions as a cell culture scaffold, because the bulky structure is beneficial for the proliferation of cells. Accordingly, the biodegradable suture-type cell delivery system can improve the rate of engraftment of stem cells in vivo.

Abstract: The present invention relates to a sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases. More particularly, the present invention relates to a pharmaceutical composition, containing as an active ingredient a sesquiterpene lactone-based derivative derived from parthenolide, for preventing or treating gastritis or gastric ulcers.

Abstract: The present invention relates to a sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases. More particularly, the present invention relates to a pharmaceutical composition, containing as an active ingredient a sesquiterpene lactone-based derivative derived from parthenolide, for preventing or treating gastritis or gastric ulcers.